📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cerexa

1.1 - Company Overview

Cerexa Logo

Cerexa

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel anti-infective therapies for serious and life-threatening infections; develops a portfolio of treatments including Ceftaroline Acetate/Ceftaroline, an injectable cephalosporin used for bacterial infections.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cerexa

Helix BioMedix Logo

Helix BioMedix

HQ: United States Website
  • Description: Provider of skin health consumer products and bioactive peptide solutions for dermatological and personal care, including a proprietary peptide library with antimicrobial, anti-inflammatory and wound healing properties; SmartPeptides to enhance skin appearance; Oligopeptide-10 for acne; Palmitoyl Hexapeptide-14 and Hexapeptide-21 to stimulate collagen; and HB4208, a preclinical DNA Damage Response enzyme for Xeroderma Pigmentosum.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Helix BioMedix company profile →
Alpha-Tec Systems Logo

Alpha-Tec Systems

HQ: United States Website
  • Description: Provider of accurate specimen collection, transportation, processing, and quality control solutions for clinical labs, including AFB processing systems (NAC-PAC EA3, UNITARY, RED), fertility and immune testing products (QC-Beads, CitricScreen, FructoScreen, LeucoScreen, ImmunoSpheres, MarScreen), Microbix REDx and PROCEEDx controls, and the OxA oxalic acid decontamination kit for Pseudomonas spp.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alpha-Tec Systems company profile →
60 Degrees Pharmaceuticals Logo

60 Degrees Pharmaceuticals

HQ: United States Website
  • Description: Provider of medicines to treat and prevent infectious diseases, including ARAKODA (tafenoquine) for malaria prophylaxis in patients 18+, a Dengue Fever Treatment Program developing 60P001 (alpha-glucosidase inhibitor) and 60P002 (platelet-activating factor receptor antagonist), and a Malaria Prevention Program developing new drugs to address limitations of existing prophylactics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 60 Degrees Pharmaceuticals company profile →
Spring Bank Pharmaceuticals Logo

Spring Bank Pharmaceuticals

HQ: United States Website
  • Description: Provider of small molecule nucleic acid hybrid-based therapeutics and immuno-oncology candidates, including FS118, a LAG-3/PD-L1 mAb2 bispecific antibody in Phase 2 for head and neck cancer, NSCLC and DLBCL; FS120, an OX40/CD137 dual agonist mAb2 in Phase 1; FS222, a CD137/PD-L1 mAb2 in Phase 1 for PD-L1-low tumors; and SB 11285, an IV second-generation STING agonist in Phase 1, alone and with atezolizumab.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spring Bank Pharmaceuticals company profile →
F2G Logo

F2G

HQ: United Kingdom Website
  • Description: Provider of novel antifungal drug discovery and development, advancing patented compounds and technologies to treat life-threatening fungal diseases. Founded on proprietary genomics technology (MycoBank) that identifies essential gene targets in fungi.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full F2G company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cerexa

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cerexa

2.2 - Growth funds investing in similar companies to Cerexa

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cerexa

4.2 - Public trading comparable groups for Cerexa

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cerexa

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cerexa

What does Cerexa do?

Cerexa is a provider of novel anti-infective therapies for serious and life-threatening infections; develops a portfolio of treatments including Ceftaroline Acetate/Ceftaroline, an injectable cephalosporin used for bacterial infections.

Who are Cerexa's competitors?

Cerexa's competitors and similar companies include Helix BioMedix, Alpha-Tec Systems, 60 Degrees Pharmaceuticals, Spring Bank Pharmaceuticals, and F2G.

Where is Cerexa headquartered?

Cerexa is headquartered in United States.

How many employees does Cerexa have?

Cerexa has 1,000 employees 🔒.

When was Cerexa founded?

Cerexa was founded in 2010 🔒.

What sector and industry vertical is Cerexa in?

Cerexa is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cerexa

Who are the top strategic acquirers in Cerexa's sector and industry

Top strategic M&A buyers and acquirers in Cerexa's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cerexa?

Top strategic M&A buyers groups and sectors for Cerexa include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cerexa's sector and industry vertical

Which are the top PE firms investing in Cerexa's sector and industry vertical?

Top PE firms investing in Cerexa's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cerexa's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cerexa's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cerexa's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cerexa include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cerexa's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cerexa?

The key public trading comparables and valuation benchmarks for Cerexa include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cerexa for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cerexa with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cerexa's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cerexa with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cerexa's' sector and industry vertical?

Access recent funding rounds and capital raises in Cerexa's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cerexa